NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,294,000 | +58.0% | 2,028,204 | -0.1% | 0.00% | +50.0% |
| Q4 2018 | $3,350,000 | -72.3% | 2,030,204 | -18.6% | 0.00% | -66.7% |
| Q3 2018 | $12,092,000 | -15.9% | 2,493,239 | +8.4% | 0.01% | -14.3% |
| Q2 2018 | $14,374,000 | -24.7% | 2,299,739 | -0.0% | 0.01% | -30.0% |
| Q1 2018 | $19,097,000 | -22.4% | 2,300,839 | -4.7% | 0.01% | -16.7% |
| Q4 2017 | $24,614,000 | +14.9% | 2,413,139 | +3.1% | 0.01% | +9.1% |
| Q3 2017 | $21,426,000 | +34.9% | 2,341,600 | +7.6% | 0.01% | +37.5% |
| Q2 2017 | $15,887,000 | +1.4% | 2,176,300 | +0.0% | 0.01% | 0.0% |
| Q1 2017 | $15,668,000 | +103.6% | 2,176,100 | +65.4% | 0.01% | +100.0% |
| Q4 2016 | $7,696,000 | -11.0% | 1,315,500 | +0.1% | 0.00% | -20.0% |
| Q3 2016 | $8,650,000 | -21.6% | 1,314,700 | +10.5% | 0.01% | -16.7% |
| Q2 2016 | $11,039,000 | -14.7% | 1,189,600 | -0.8% | 0.01% | -14.3% |
| Q1 2016 | $12,935,000 | -27.9% | 1,198,797 | -4.3% | 0.01% | -22.2% |
| Q4 2015 | $17,930,000 | -3.9% | 1,252,114 | +41.0% | 0.01% | 0.0% |
| Q3 2015 | $18,662,000 | – | 888,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|